numerator glp 1 9% of Saudi households use GLP-1, driving SAR 7.3bn (€1.7bn) in FMCG spend and a shift towards healthier lifestyles US households with GLP-1 users
Description
ColonBroom positions itself as a natural, non-invasive alternative for those who want similar appetite support without medical barriers
Doubling doses is not recommended
Bagatin E, Costa CS
Exendin-4, by contrast, proved resistant to DPP-4 degradation
The resulting longer gastric retention enhances satiety, reduces overall food intake, and contributes to weight management
Programs can titrate doses, monitor side effects, and adjust treatment based on individual response
